Soleus Capital Management, L.P. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2023$508,800
-90.4%
320,000
-94.3%
0.06%
-92.1%
Q3 2022$5,308,000
+438.3%
5,587,789
+5488.2%
0.72%
+305.1%
Q1 2021$986,000
-33.1%
99,992
-26.5%
0.18%
-8.2%
Q4 2020$1,474,000
-60.7%
135,992
-62.7%
0.19%
-90.2%
Q3 2020$3,753,000
-17.8%
364,349
+66.6%
1.99%
-23.6%
Q2 2020$4,566,000
+48.9%
218,723
-30.3%
2.60%
-27.1%
Q1 2020$3,067,000
-22.3%
313,900
-8.4%
3.57%
-6.3%
Q4 2019$3,949,000342,8003.81%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2020
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders